UConn's 2025 Fall Career Fair
2025-09-29 - 2025-10-01 | UConn Student Union
UConn’s Fall Career Fair is now open!
Our Fall Fair will be 3 days this year and held in the Student Union due to exciting renovations to our traditional (larger) site, Gampel Pavilion.

DAY 1 (Monday, 9/29) will focus on STEM industries and those hiring STEM majors.
DAY 2 (Tues, 9/30) will feature a mix of employers and students – both STEM and all majors.
DAY 3 (Wed, 10/1) will be for non-STEM industries and majors.

Not sure which day/days you should attend? We’re happy to talk it out – just call our friendly employer relations team – 860-486-3013 or email career.fair@uconn.edu.
Click here to register for the fair and log into our new platform, hosted by 12twenty. No 12twenty account yet? Click here to set it up.

Align Summit - Hosted by MassBio
2025-10-07 | Boston Marriott Coply Place, 110 Huntington Avenue, Boston, MA, 02116
MassBio’s annual early-stage and funder partnering conference, Align Summit, with insights from McKinsey and Locust Walk, builds relationships between funders and biotech startups and small companies by showcasing the best and the brightest in the life sciences.
Through presentations by emerging life sciences companies, thought leadership sessions, and partnering meetings, the 2025 Align Summit will look to a brighter future by focusing on the next generation therapies and the rapidly-expanding promise of techbio.
The application to present at Align Summit is now open until June 20 at 12:00 PM (noon). If your Seed to Series B company fits the criteria outlined below, we encourage you to apply. This year’s presentation tracks are:

AI/ML-Driven Drug Design, Discovery, Development: This track will highlight companies using artificial intelligence and machine learning (AI/ML) to transform drug discovery and development.
Next-Generation Multispecific Therapeutics: This track will feature companies focused on cutting-edge advancements in multi-specific therapies, emphasizing their ability to address complex biological pathways and improve targeted delivery mechanisms.
The Future of Precision Therapies: This track will feature companies focused using precision therapies that customize treatments based on individual genetic, molecular, or biomarker profiles.

Presenting Companies | Please click here for details and the application form.

CT ACS CAN 10th annual David “Coach” Koch Connecticut Policy Forum – Celebrating Connecticut as a Driver of Innovation Across the Cancer Continuum
2025-10-16 | The Jackson Laboratory, 10 Discovery Drive, Farmington, CT, 06032
Connecticut stands as a beacon of innovation across the cancer care continuum, leveraging its rich history of medical advancements, research, and collaboration to improve outcomes for patients worldwide. From the development of precision medicine therapies to advances in immunotherapy, Connecticut’s contributions have reshaped how cancer is diagnosed and treated.
This event will celebrate our successes while looking at today’s landscape including opportunities and challenges the next decade may bring in assuring Connecticut remains a national leader in cancer care innovation. The first half hour will be for sign in and networking with the program beginning at 8:30.
The following Speakers are confirmed for the Forum:

Karolina Palucka, M.D., Ph.D. – Professor, Director, Jackson Laboratory Cancer Center, Edison T. Liu Endowed Chair in Cancer Research
Katerina Politi, Ph.D. – Co-Leader, Cancer Signaling Networks, Yale Cancer Center; Scientific Director, Center for Thoracic Cancers (ACS Funded Researcher)
Ranjit S. Bindra, M.D., Ph.D. – Scientific Director, Yale Brain Tumor Center
Steven Shichman, M.D. Physician in Chief of the Tallwood Urology and Kidney Institute, Hartford HealthCare, and Medical Director of the HHC Center for Education, Simulation, and Innovation
Mary Dickenson, Ph.D. – Executive Vice President & Chief Scientific Officer at the Jackson Laboratory for Genomic Medicine
Francesca Menghi, Ph.D. Senior Research Scientist at the Jackson Laboratory for Genomic Medicine
Kyla Elizabeth Driscoll, MD. Lilly Head, Discovery Strategy and Scientific Operations Oncology Research
Monica Shaw, MD. – Senior Vice President of Global Oncology Commercialization and US Operations for Hematology/Oncology, Bristol Myers Squibb

Participants will include diverse stakeholders in our communities – patient advocates, payors, health systems, business leaders, providers, patients, and lawmakers.
Please note: Registration is required. To register for this free event

NORD Rare Diseases& Orphan Products Breakthrough Summit
2025-10-19 - 2025-10-21 | Grand Hyatt, 1000 H Street NW, Washington, DC, 20001
Shape the future of rare disease treatments, research and policy at the NORD® Rare Diseases and Orphan Products Breakthrough Summit.® Together, we can advance innovation for the more than 30 million Americans – and more than 400 million people worldwide – with rare diseases!
Event Information
Agenda
